Paper35995339
Burden of hospital-acquired SARS-CoV-2 infections in Germany: occurrence and outcomes of different variants.
Bonsignore M and 8 others. J Hosp Infect, 2022. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. Burden of hospital-acquired SARS-CoV-2 infections in Germany: occurrence and outcomes of different variants. Papers, record 35995339. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35995339
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Burden of hospital-acquired SARS-CoV-2 infections in Germany: occurrence and outcomes of different variants.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| COVID-19 | Major topic |
| Cross Infection | Major topic |
| Humans | |
| SARS-CoV-2 | |
| Pandemics | |
| Germany | |
| Hospitals |
Source PubMed
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42528337 | Mathematical Modeling of Viral RNA Copies in Indoor Environments: Pre-Processor for Risk Assessment and Decision-Making Support Tool for Public Health. | Risk Anal | 2026 | https://conductscience.org/library/papers/42528337 | PubMed |
| 41899213 | Lessons from Two Early COVID-19 Hospital Outbreaks in Germany to Inform Strategies for Controlling Emerging Nosocomial Outbreaks of Highly Transmissible Respiratory Viruses. | J Clin Med | 2026 | https://conductscience.org/library/papers/41899213 | PubMed |
| 39919135 | Health-economic evaluation of the outpatient, inpatient, and public health sector in Germany: Insights from the first three COVID-19 waves. | PLoS One | 2025 | https://conductscience.org/library/papers/39919135 | PubMed |
| 39449698 | Hospital-borne hazardous air pollutants and air cleaning strategies amid the surge of SARS-CoV-2 new variants. | Heliyon | 2024 | https://conductscience.org/library/papers/39449698 | PubMed |
| 39335015 | Incidence and Predictors of Healthcare-Associated Infections in Patients Admitted to a Temporary Intensive Care Unit during the COVID-19 Pandemic Waves: A Two-Year (2021-2023) Retrospective Cohort Study in Rome, Italy. | Antibiotics (Basel) | 2024 | https://conductscience.org/library/papers/39335015 | PubMed |
| 39187755 | SARS-CoV-2 infections in patients, health care workers and hospital outbreaks during the first 3 waves of the pandemic: a retrospective analysis in a secondary care hospital network in Germany. | BMC Infect Dis | 2024 | https://conductscience.org/library/papers/39187755 | PubMed |
| 39008853 | Morbidity and Mortality of Hospital-Onset SARS-CoV-2 Infections Due to Omicron Versus Prior Variants : A Propensity-Matched Analysis. | Ann Intern Med | 2024 | https://conductscience.org/library/papers/39008853 | PubMed |
| 38932363 | Retrospective, Observational Analysis on the Impact of SARS-CoV-2 Variant Omicron in Hospitalized Immunocompromised Patients in a German Hospital Network-The VISAGE Study. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/38932363 | PubMed |
| 38806219 | Ventilator-Associated Pneumonia, Ventilator-Associated Events, and Nosocomial Respiratory Viral Infections on the Leeside of the Pandemic. | Respir Care | 2024 | https://conductscience.org/library/papers/38806219 | PubMed |
| 38156200 | Incidence and outcome of hospital-acquired COVID-19 infections in secondary and tertiary care hospitals in the era of COVID-19 vaccinations. | Antimicrob Steward Healthc Epidemiol | 2023 | https://conductscience.org/library/papers/38156200 | PubMed |
| 37948082 | Nosocomial SARS-CoV-2 Infections and Mortality During Unique COVID-19 Epidemic Waves. | JAMA Netw Open | 2023 | https://conductscience.org/library/papers/37948082 | PubMed |
| 37639273 | Assessment of Hospital-Onset SARS-CoV-2 Infection Rates and Testing Practices in the US, 2020-2022. | JAMA Netw Open | 2023 | https://conductscience.org/library/papers/37639273 | PubMed |
| 37162815 | Estimating time-dependent contact: a multi-strain epidemiological model of SARS-CoV-2 on the island of Ireland. | Glob Epidemiol | 2023 | https://conductscience.org/library/papers/37162815 | PubMed |
| 37125157 | Elder and booster vaccination associates with decreased risk of serious clinical outcomes in comparison of Omicron and Delta variant: A meta-analysis of SARS-CoV-2 infection. | Front Microbiol | 2023 | https://conductscience.org/library/papers/37125157 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35995339
GET https://conductscience.org/api/papers/v1/35995339/authors